Modifications on histones control important biological processes through their effects on chromatin structure [1] [2] [3] . Methylation at lysine 4 on histone H3 (H3K4) is found at the 59 end of active genes and contributes to transcriptional activation by recruiting chromatin-remodelling enzymes 4, 5 . An adjacent arginine residue (H3R2) is also known to be asymmetrically dimethylated (H3R2me2a) in mammalian cells 6 , but its location within genes and its function in transcription are unknown. Here we show that H3R2 is also methylated in budding yeast (Saccharomyces cerevisiae), and by using an antibody specific for H3R2me2a in a chromatin immunoprecipitation-on-chip analysis we determine the distribution of this modification on the entire yeast genome. We find that H3R2me2a is enriched throughout all heterochromatic loci and inactive euchromatic genes and is present at the 39 end of moderately transcribed genes. In all cases the pattern of H3R2 methylation is mutually exclusive with the trimethyl form of H3K4 (H3K4me3). We show that methylation at H3R2 abrogates the trimethylation of H3K4 by the Set1 methyltransferase. The specific effect on H3K4me3 results from the occlusion of Spp1, a Set1 methyltransferase subunit necessary for trimethylation. Thus, the inability of Spp1 to recognize H3 methylated at R2 prevents Set1 from trimethylating H3K4. These results provide the first mechanistic insight into the function of arginine methylation on chromatin.
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Methylation at lysine and arginine residues within histones has been linked to gene expression [1] [2] [3] . Studies in mammalian cells have shown that arginine methylation of histones can influence both gene activation and repression. However, the precise mechanism employed by arginine methylation to exert its effects on the chromatin template is still unknown. In contrast, increasing evidence shows that lysine methylation modulates gene expression by recruiting downstream effector proteins. Recent findings showed that methylation at H3K4 (H3K4me) controls transcription activation by recruiting chromatin remodelling activities 4, 5 . This recruitment can be specific for H3K4me3 (refs 7, 8) , indicating that the three different methyl states of H3K4 (monomethylated, dimethylated and trimethylated) have distinct functions in gene expression. The Set1 complex is the enzyme that can mediate the methylation of H3K4, and various components of the complex regulate the establishment of the different methyl-H3K4 states [9] [10] [11] . To investigate the role of methylation at H3R2 in gene expression we raised an antibody against H3R2me2a. This modification is known to be catalysed by the mammalian CARM1/PRMT4 in vitro 12 and is affected by deletion of this methyltransferase in mouse embryonic fibroblasts 6 . Immunoblot analysis reveals that H3R2me2a is present in vivo, on mammalian and yeast histone H3 ( Supplementary Fig. 1a, b) .
We confirmed the specificity of this antibody towards H3R2me2a by dot-blot analysis and peptide competition assays ( Supplementary  Fig. 1c, d ). Most importantly, the antibody does not recognize histone H3 in yeast cells in which arginine 2 has been mutated to an alanine residue (H3R2A), a glutamine residue (H3R2Q) or a lysine residue (H3R2K) ( Supplementary Figs 1e and 2) .
To examine the specific function of H3R2 methylation, we used a high-resolution chromatin immunoprecipitation (ChIP)-on-chip analysis in yeast to determine its genome-wide distribution. We found that this mark is associated with both heterochromatin and euchromatin (Figs 1 and 2) . Analysis of heterochromatin showed that H3R2me2a is present at all four heterochromatic regions in yeast: the two silent mating-type loci (HMR and HML), the ribosomal RNAencoding DNA (rDNA repeat) and telomeres ( Fig. 1a-d) . In this analysis it became clear that all heterochromatic regions that were enriched in H3R2 methylation were also devoid of the active methyl mark H3K4me3 (Fig. 1a-d) . Indeed, the decrease in H3R2me2a and increase in H3K4me3 levels can be used to define the boundaries of heterochromatic regions.
The presence of H3R2me2a at heterochromatic sites indicates that this methylation may be part of a signal to silence transcription. We therefore used yeast strains expressing the H3R2 mutants H3R2A and H3R2Q to test the role of this residue in heterochromatic silencing. We found that mutation of arginine 2 resulted in a severe loss of silencing in the HMR, telomere and rDNA loci, and to a moderate extent at the HML locus ( Fig. 1e and Supplementary Fig. 3 , left panels). These results indicate that arginine 2 on H3 is necessary for heterochromatic silencing, indicating a possible role for H3R2 methylation in this process.
We next considered the mechanism by which H3R2me2a may function to regulate heterochromatin. Comparison of the occupancy of key heterochromatic factors, such as Rap1p and Sir2p, with H3R2me2a enrichment indicates a coincidence at telomeric sites (compare Fig. 1d with Fig. 1f) . However, when ChIP analysis of Rap1p and Sir2p was compared in wild-type (WT) and H3R2A strains the amount of binding of these two proteins at the heterochromatic sites was not changed (Fig. 1f) . These results indicate that methylation at H3R2 functions at heterochromatin through a previously unobserved mechanism, which is independent of Rap1p and Sir2p recruitment. However, we cannot exclude the possibility that disruption of H3K4 methylation may contribute to the H3R2A phenotype (see below).
To determine the role of H3R2me2a within euchromatin, we divided 5,065 genes into five groups according to their transcriptional rate 13 (designated by shades of blue in Fig. 2a ). We then examined the average enrichment of H3R2me2a for each gene group.
Composite profiles indicate that H3R2me2a occurs near the middle of the coding region and peaks towards the 39 end of genes (Fig. 2a) . The H3R2me2a enrichment is inversely correlated with transcriptional activity because this mark is most abundant on the least active genes.
A role for H3R2 methylation in transcriptional repression was also highlighted by comparing its genomic profile with the pattern of H3K4me3, which is a signal for active transcription. Figure 2b shows that H3K4me3 is found at the 59 end of genes, which is consistent with previous studies 14, 15 , and that it is most enriched at the most active genes (darker shades of blue). We noticed that H3K4me3 is enriched in the region of a gene at which H3R2me2a is missing, suggesting an antagonistic relationship between these two modifications (Fig. 2a, b) .
To investigate the relationship of H3R2me2a with all H3K4 methyl states we divided all genes into three transcriptional categories (inactive, moderately transcribed and highly transcribed) and then compared the distribution of H3R2me2a with that of the three methyl-H3K4 marks (H3K4me1, H3K4me2 and H3K4me3) across individual genes. In all three transcriptional states the pattern of H3R2me2a was mutually exclusive with H3K4me3 specifically (Fig. 2c-e and Supplementary Fig. 4 ). This inverse enrichment between H3R2me2a and H3K4me3 is not seen with trimethylation of the other two known modified lysines in yeast, H3K36me3 and H3K79me3 (data not shown). The inverse profiles of H3R2me2a and H3K4me3 were not due to failure of the anti-H3R2me2a and antiH3K4me3 antibodies to recognize their epitope when the adjacent residue is methylated ( Supplementary Fig. 1c ). These results indicate that H3R2me2a covers the promoter and coding region of silent genes but, as the transcription rate is increased, H3R2me2a recedes from the 59 end and is replaced by H3K4 trimethylation. Fig. 9 ).
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ChIP analysis of cells grown in repressive conditions (glucose) showed high enrichment of H3R2me2a at GAL genes, whereas H3K4me3 was not detected at all on the same loci (Fig. 2f, grey bars) . Shifting the cells to activating conditions (galactose) completely reversed the levels of the two modifications at those same locations (Fig. 2f, black bars) . This analysis confirms the inverse correlation observed between H3R2me2a and H3K4me3, and shows that the two modifications are dynamically regulated together in the sense that when one mark is removed from nucleosomes the other is incorporated.
The dynamic exchange of these two modifications on nucleosomes suggested that the arginine residue at position 2 of histone H3 might have a direct function in regulating the methylation at the adjacent lysine 4. We examined this possibility by analysing the global methylation levels at H3K4 in yeast strains carrying mutations at H3R2 (H3R2A, H3R2Q and H3R2K). Figure 3a and Supplementary Fig.  2 show that in the H3R2A and H3R2Q strains the H3K4me3 signal is abolished, whereas in the H3R2K strain the H3K4me3 signal is greatly reduced. The H3K4me1 and H3K4me2 are, respectively, unaffected or very slightly reduced in these mutant strains (Fig. 3a, lane 3, and Supplementary Fig. 2, lanes 2-4) . The disruption of H3K4me3 by mutating H3R2 is specific, because the H3R2A mutation does not affect the trimethyl state at the other methylated sites, namely H3K36 and H3K79 (Fig. 3a, lane 3) . The loss of the H3K4me3 signal in the H3R2A mutant is not due to failure of the anti-H3K4me3 antibody to recognize its epitope when arginine 2 is mutated ( Supplementary Fig.  5 , lane 3, left and right panels).
The fact that trimethylation of H3K4 defines active transcription 16 prompted us to examine whether the H3R2A mutation affected gene expression. We tested the kinetics of GAL1 and GAL7 induction in the wild type and in H3R2A and H3K4A mutant strains. Figure 3b shows that mutation of H3R2 delays the activation of GAL genes. The effect of the H3R2A mutation is similar to, but less severe than, that of the H3K4A mutation, indicating that these two residues might be involved in a common regulatory mechanism (Fig. 3b) . We next sought to determine the mechanism responsible for the inverse distribution between H3R2me2 and H3K4me3. We first considered the possibility that H3R2 forms part of the recognition site for the Set1 complex, which methylates H3K4. Figure 3c shows that purified Set1 complex from yeast is able to methylate an unmodified H3 peptide but its activity is inhibited by mutation of arginine 2 to alanine (compare lane 2 with lane 4). Asymmetric dimethylation at H3R2 also inhibits the activity of the Set1 complex towards lysine 4 (Fig. 3c , compare lane 1 with lane 2). This Set1p activity is specific for lysine 4, because a peptide that is already trimethylated at H3K4 shows only background signal (Fig. 3c, lane 3) . In addition, peptide sequencing reveals that the activity of the Set1 complex is occurring only at residue 4 ( Supplementary Fig. 6 ). These results indicate that H3R2 is a recognition site for the Set1p methylase complex and also that methylation of H3R2 inhibits the Set1p enzyme from methylating H3K4.
The ability of Set1p to catalyse monomethylation, dimethylation or trimethylation at H3K4 is regulated by several components of the Set1 complex. Specifically, the Spp1 subunit is required for Set1-mediated trimethylation of H3K4 (ref. 10) . It has been shown recently that Spp1 binds specifically to H3K4me2 and H3K4me3 through its PHD domain 17 . We therefore examined whether methylation of H3R2 is required for the binding of Spp1 to methylated lysine 4 in vitro. Figure 4a shows that dimethylation of H3R2 inhibits the interaction of the Spp1 PHD finger with dimethylated or trimethylated K4 (compare lanes 3 and 5 with lanes 4 and 6). Mutation of H3R2 also disrupts the binding of Spp1, which is consistent with the fact that this arginine residue is part of the recognition site of the Spp1 PHD finger 17 ( Supplementary Fig. 7 ). To determine whether H3R2me2a also blocks Spp1 binding in vivo we performed ChIP assays in a yeast strain expressing Myc-tagged Spp1. Figure 4b and Supplementary Fig. 8 show that Spp1 is bound to regions of genes that were trimethylated at H3K4 and were devoid of H3R2me2a. However, Spp1 was absent from areas of genes at which H3R2 methylation was present, even though H3K4me1 or H3K4me2 was also abundant in these regions (Fig. 4b , middle panel, and Supplementary Fig. 8 ). These results confirm the biochemical analysis in Fig. 4a , which shows that H3R2 methylation can prevent Spp1 from binding H3K4me2. Moreover, the above observations that H3K4me3 is absent from regions in which H3R2me2a is enriched are consistent with the occlusion of Spp1.
Together these results identify the existence and indicate the function of H3R2 methylation in yeast. H3R2 methylation regulates the activity of the Set1 complex towards H3K4 by modulating the binding of its Spp1 component. The role of H3R2me2a in controlling H3K4me3 is also conserved in humans 18 , indicating that this mechanism is likely to be generally applicable in all eukaryotes.
These findings place methylation at H3R2 and H3K4 in the same pathway and support a role of H3R2me2a as a negative regulator of H3K4 trimethylation. Figure 4c shows a model of how H3R2me2a may function during the transition from a repressed to a transcriptionally active state on a gene. Global analysis shows that when a gene is inactive, H3R2me2a is present throughout the promoter and coding region (step 0). Methylation of H3R2 in yeast is likely to be catalysed by a previously unknown and as yet unidentified methyltransferase, because combinatorial deletion of the three known arginine methyltransferases (Rmt1, Rmt2 and Hsl7) does not affect the degree of this modification (data not shown). At this silent stage (step 0) very little, if any, methylation of H3K4 takes place. During activation, the presence of methylated H3R2 does not inhibit Set1p from monomethylating or dimethylating H3K4 (step 1). However, for trimethylation of H3K4 to take place, methylation at H3R2 has to be removed (step 2). The clearing of methylation at H3R2 must be mediated either by histone replacement or by the action of an as yet unidentified arginine demethylase. Once a region becomes devoid of H3R2 methylation, the Spp1 protein can recognize H3K4me2 by its PHD domain. This binding probably extends the time of interaction between the Set1 complex and its substrate, thus promoting the trimethylation of H3K4 by Set1p (step 3 (ref. 19) ). Spp1 then associates with H3K4me3 (step 4), possibly to protect this methyl state from the action of the H3K4me3 demethylase Jhd2 (refs 20, 21) . At the same time, Spp1 may protect H3R2 from methylation; structural studies 17, 22, 23 have shown that this arginine residue is absolutely required for the association of the Spp1 PHD finger with methylated H3K4. Together these data indicate that arginine methylation at H3R2 may influence transcription by regulating the H3K4 trimethylation capacity of the Set1 methyltransferase.
METHODS SUMMARY
Formaldehyde crosslinking and ChIP were performed as described previously 24 , with the following exceptions: the immunocomplexes were eluted from the Sepharose beads (17-5280-01; Amersham) using a total of 200 ml of elution buffer (100 mM sodium bicarbonate, 1% SDS), and treatment with RNase (11119915001; Roche) was performed during reversal of the crosslinks at 65 uC for 5 h. After reversal of the crosslinks, each individual ChIP sample was purified with the Qiaquick polymerase chain reaction (PCR) purification kit (Qiagen) and DNA was eluted from the columns with 50 ml of EB buffer (10 mM Tris-HCl pH 8.5). Amplicons were generated from individual ChIP samples by using a linker-mediated PCR. Sample labelling, hybridization and data extraction were performed by NimbleGen Systems Inc. as part of a ChIP Array Service. Downstream analysis of the ChIP-on-chip data was performed with the statistical package R (www.R-project.org) and associated array analysis modules in Bioconductor.
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